We are live on ! Find out more
IVM

InterWest Venture Management Portfolio holdings

AUM $20.6M
1-Year Est. Return 48.5%
This Fund
S&P 500
This Quarter Est. Return
+10.72%
1 Year Est. Return
+48.5%
3 Year Est. Return
-57.65%
5 Year Est. Return
-76.52%
10 Year Est. Return
–
AUM
$205M
AUM Growth
-$32M
Cap. Flow
-$48.1M
Cap. Flow %
-23.51%
Top 10 Hldgs %
99.95%
Holding
12
New
–
Increased
2
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
VERO
Venus Concept
VERO
+$5.08M
2
KALV
KalVista Pharmaceuticals
KALV
+$795K

Top Sells

Rank Stock Value
1
GKOS icon
Glaukos
GKOS
+$49.8M
2
IVTY
Invuity, Inc
IVTY
+$4.21M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSRO
1
DELISTED
TESARO, Inc.
TSRO
$78.9M 38.51%
2,021,738
– –
STIM icon
2
Neuronetics
STIM
$125M
$33M 16.14%
1,030,689
– –
MGNX icon
3
MacroGenics
MGNX
$241M
$23M 11.25%
1,074,316
– –
EIGR
4
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$19.2M 9.37%
53,320
– –
VERO
5
DELISTED
Venus Concept
VERO
$15.5M 7.58%
2,164
+808
+60% +$5.08M
AGTC
6
DELISTED
Applied Genetic Technologies Corporation
AGTC
$10.6M 5.19%
1,455,904
– –
HIND
7
Vyome Holdings
HIND
$14M
– –
0
– –
KALV
8
DELISTED
KalVista Pharmaceuticals
KALV
$8.6M 4.2%
388,766
+58,824
+18% +$795K
CDTX
9
DELISTED
Cidara Therapeutics
CDTX
$5.97M 2.92%
67,841
– –
GKOS icon
10
Glaukos
GKOS
$8.75B
$218K 0.11%
3,362
-1,015,000
-100% -$49.8M
XENE icon
11
Xenon Pharmaceuticals
XENE
$6.29B
$109K 0.05%
8,293
– –
IVTY
12
DELISTED
Invuity, Inc
IVTY
– –
-1,080,272
Closed -$4.21M

Similar funds

RCP
Rho Capital Partners New York $20.4M AUM
LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return

InterWest Venture Management's Q3 2018 Portfolio in Review

As of Q3 2018, InterWest Venture Management held 12 positions worth $205M, down 14% from $237M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

InterWest Venture Management withdrew a net $48.1M in Q3 2018, closing 1 position and reducing 1 holding. Its most notable exit was Invuity, Inc, an estimated $4.21M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, InterWest Venture Management added an estimated $5.08M to Venus Concept.

  • InterWest Venture Management added most to Venus Concept in Q3 2018, an estimated $5.08M increase.
  • InterWest Venture Management's biggest Q3 2018 reduction was Glaukos, cutting an estimated $49.8M.
  • InterWest Venture Management fully exited Invuity, Inc in Q3 2018, selling an estimated $4.21M.
  • InterWest Venture Management's ten largest holdings make up 100% of its $205M portfolio in Q3 2018.
  • InterWest Venture Management opened 0 new positions and closed 1 in Q3 2018.
  • InterWest Venture Management's portfolio value fell 14% quarter-over-quarter to $205M.

Based on InterWest Venture Management's 13F filing for Q3 2018, filed 4 Oct 2018.